Lynx1 shifts α4β2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum

Journal of Biological Chemistry

Volumn 289, Issue 45, 2014, Pages 31423-31432

  Nichols, Weston A ^a   Henderson, Brandon J ^a   Yu, Caroline ^a   Parker, Rell L ^a   Richards, Christopher I ^b   Lester, Henry A ^a   Miwa, Julie M ^a,c  

^a California Institute of Technology   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEHIGH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS; STOICHIOMETRY;

DIRECT MODULATION; ENDOPLASMIC RETICULUM; GLYCOSYLPHOSPHATIDYLINOSITOL; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; LOW SENSITIVITY; NICOTINIC RECEPTOR; PHARMACOLOGICAL EFFECTS; RECEPTOR-BINDING PROTEINS;

CELL MEMBRANES;

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NICOTINIC RECEPTOR ALPHA4BETA2; PROTEIN LYNX1; UNCLASSIFIED DRUG; ACETYLCHOLINE; CYSTEINE; GREEN FLUORESCENT PROTEIN; LYNX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPEPTIDE; NICOTINIC RECEPTOR; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DATA ANALYSIS; DIMERIZATION; EMBRYO; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL CULTURE; NEUROBLASTOMA CELL LINE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; STOICHIOMETRY; ANIMAL; CHEMISTRY; CONFOCAL MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PLASMID; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ACETYLCHOLINE; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CYSTEINE; ENDOPLASMIC RETICULUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICROSCOPY, CONFOCAL; NEUROPEPTIDES; PLASMIDS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, NICOTINIC;

EID: 84909619794     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.573667     Document Type: Article

References (43)

1. Miwa, J. M., Freedman, R., and Lester, H. A. (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70, 20-33
2. Jensen, A. A., Frølund, B., Liljefors, T., and Krogsgaard-Larsen, P. (2005) Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48, 4705-4745
3. Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., and Zoli, M. (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem. Pharmacol. 78, 703-711
4. Moroni, M., Zwart, R., Sher, E., Cassels, B. K., and Bermudez, I. (2006) α4β2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol. Pharmacol. 70, 755-768
5. Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., and Lindstrom, J. (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol. Pharmacol. 63, 332-341
6. Srinivasan, R., Henderson, B. J., Lester, H. A., and Richards, C. I. (2014) Pharmacological chaperoning of nAChRs:Atherapeutic target for Parkinson's disease. Pharmacol. Res. 83, 20-29
7. Miwa, J. M., Ibanez-Tallon, I., Crabtree, G. W., Sánchez, R., Sali, A., Role, L. W., and Heintz, N. (1999) lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron 23, 105-114
8. Lyukmanova, E. N., Shenkarev, Z. O., Shulepko, M. A., Mineev, K. S., D'Hoedt, D., Kasheverov, I. E., Filkin, S. Y., Krivolapova, A. P., Janickova, H., Dolezal, V., Dolgikh, D. A., Arseniev, A. S., Bertrand, D., Tsetlin, V. I., and Kirpichnikov, M. P. (2011) NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1. J. Biol. Chem. 286, 10618-10627
9. Miwa, J. M., Lester, H. A., and Walz, A. (2012) Optimizing cholinergic tone through lynx modulators of nicotinic receptors: implications for plasticity and nicotine addiction. Physiology 27, 187-199
10. Chimienti, F., Hogg, R. C., Plantard, L., Lehmann, C., Brakch, N., Fischer, J., Huber, M., Bertrand, D., and Hohl, D. (2003) Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 12, 3017-3024
11. Morishita, H., Miwa, J. M., Heintz, N., and Hensch, T. K. (2010) Lynx1, a cholinergic brake, limits plasticity in adult visual cortex. Science 330, 1238-1240
12. Miwa, J. M., Stevens, T. R., King, S. L., Caldarone, B. J., Ibanez-Tallon, I., Xiao, C., Fitzsimonds, R. M., Pavlides, C., Lester, H. A., Picciotto, M. R., and Heintz, N. (2006) The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron 51, 587-600
13. Miwa, J. M., and Walz, A. (2012) Enhancement in motor learning through genetic manipulation of the Lynx1 gene. PLoS One 7, e43302
14. Tekinay, A. B., Nong, Y., Miwa, J. M., Lieberam, I., Ibanez-Tallon, I., Greengard, P., and Heintz, N. (2009) A role for LYNX2 in anxiety-related behavior. Proc. Natl. Acad. Sci. U.S.A. 106, 4477-4482
15. Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez, D. F., Mackey, E. D., McKinney, S., Drenan, R. M., Richards, C. I., and Lester, H. A. (2014) Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors. J. Gen. Physiol. 143, 51-66
16. Nichols, B. J., Kenworthy, A. K., Polishchuk, R. S., Lodge, R., Roberts, T. H., Hirschberg, K., Phair, R. D., and Lippincott-Schwartz, J. (2001) Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153, 529-541
17. Cha, B., Kenworthy, A., Murtazina, R., and Donowitz, M. (2004) The lateral mobility of NHE3 on the apical membrane of renal epithelial OK cells is limited by the PDZ domain proteins NHERF1/2, but is dependent on an intact actin cytoskeleton as determined by FRAP. J. Cell Sci. 117, 3353-3365
18. Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., and Lester, H. A. (2003) Assembly of α4β2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain lneurons. J. Neurosci. 23, 11554-11567
19. Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., and Lester, H. A. (2008) Subcellular trafficking, pentameric assembly and subunit stoichiometry of neuronal nicotinic ACh receptors containing fluorescently-labeled α6 and β3 subunits. Mol. Pharmacol. 73, 27-41
20. Moss, F. J., Imoukhuede, P. I., Scott, K., Hu, J., Jankowsky, J. L., Quick, M. W., and Lester, H. A. (2009) GABA transporter function, oligomerization state, and anchoring: correlates with subcellularly resolved FRET. J. Gen. Physiol. 134, 489-521
21. Ibañez-Tallon, I., Wen, H., Miwa, J. M., Xing, J., Tekinay, A. B., Ono, F., Brehm, P., and Heintz, N. (2004) Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo. Neuron 43, 305-311
22. Miesenböck, G., De Angelis, D. A., and Rothman, J. E. (1998) Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394, 192-195
23. A receptors. J. Neurosci. 25, 10469-10478
24. Richards, C. I., Srinivasan, R., Xiao, C., Mackey, E. D., Miwa, J. M., and Lester, H. A. (2011) Trafficking of α4∗ nicotinic receptors revealed by superecliptic phluorin: effects of a β4 amyotrophic lateral sclerosis-associated mutation and chronic exposure to nicotine. J. Biol. Chem. 286, 31241-31249
25. Khiroug, S. S., Pryazhnikov, E., Coleman, S. K., Jeromin, A., Keinänen, K., and Khiroug, L. (2009) Dynamic visualization of membrane-inserted fraction of pHluorin-tagged channels using repetitive acidification technique. BMC Neurosci. 10, 141
26. Ibañez-Tallon, I., Miwa, J. M., Wang, H. L., Adams, N. C., Crabtree, G. W., Sine, S. M., and Heintz, N. (2002) Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron 33, 893-903
27. Whiteaker, P., Sharples, C. G., and Wonnacott, S. (1998) Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol. Pharmacol. 53, 950-962
28. 3 human acetylcholine receptors. Mol. Pharmacol. 71, 769-776
29. Wang, Y., Yao, Y., Tang, X. Q., and Wang, Z. Z. (2009) Mouse RIC-3, an endoplasmic reticulum chaperone, promotes assembly of the α7 acetylcholine receptor through a cytoplasmic coiled-coil domain. J. Neurosci. 29, 12625-12635
30. Alexander, J. K., Sagher, D., Krivoshein, A. V., Criado, M., Jefford, G., and Green, W. N. (2010) Ric-3 promotes α7 nicotinic receptor assembly and trafficking through the ER subcompartment of dendrites. J. Neurosci. 30, 10112-10126
31. Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., and Wang, J. C. (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry: implications for drug discovery. AAPS J. 11, 167-177
32. Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., Collins, A. C., Marks, M. J., and Lester, H. A. (2007) Chronic nicotine cell specifically upregulates functional α4∗ nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J. Neurosci. 27, 8202-8218
33. Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D., Son, C. D., Miwa, J., and Lester, H. A. (2011) Nicotine upregulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J. Gen. Physiol. 137, 59-79
34. Gault, L., Ritchie, C., Robieson, W., Pritchett, Y., Othman, A., and Lenz, R. (2013) Efficacy and safety of the alpha7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia. Alzheimer's Dementia 9, 138
35. Hauser, T. A., Kucinski, A., Jordan, K. G., Gatto, G. J., Wersinger, S. R., Hesse, R. A., Stachowiak, E. K., Stachowiak, M. K., Papke, R. L., Lippiello, P. M., and Bencherif, M. (2009) TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem. Pharmacol. 78, 803-812
36. Lieberman, J. A., Dunbar, G., Segreti, A. C., Girgis, R. R., Seoane, F., Beaver, J. S., Duan, N., and Hosford, D. A. (2013)Arandomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology 38, 968-975
37. Prickaerts, J., van Goethem, N. P., Chesworth, R., Shapiro, G., Boess, F. G., Methfessel, C., Reneerkens, O. A., Flood, D. G., Hilt, D., Gawryl, M., Bertrand, S., Bertrand, D., and König, G. (2012) EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors. Neuropharmacology 62, 1099-1110
38. Timmermann, D. B., Grønlien, J. H., Kohlhaas, K. L., Nielsen, E. Ø., Dam, E., Jørgensen, T. D., Ahring, P. K., Peters, D., Holst, D., Christensen, J. K., Malysz, J., Briggs, C. A., Gopalakrishnan, M., and Olsen, G. M. (2007) An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J. Pharmacol. Exp. Ther. 323, 294-307
39. Harvey, A., Fluck, A., Giethlen, B., Paul, D., and Schaeffer, L. (January 30, 2014) Positive allosteric modulators of the alpha 7 nicotinic acetylcholine receptor and uses thereof. U. S. Patent 20,140,031,395 A1
40. Kanner, R. (July 29, 2010) α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof. U. S. Patent 20,100,190,819 A1
41. Putman, D., and Dasse, O. (November 14, 2013) Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof. WO 2013169889 A1
42. Lester, H. A., Dibas, M. I., Dahan, D. S., Leite, J. F., and Dougherty, D. A. (2004) Cys-loop receptors: new twists and turns. Trends Neurosci. 27, 329-336
43. Buisson, B., and Bertrand, D. (2001) Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J. Neurosci. 21, 1819-1829